NDAORALTABLET, EXTENDED RELEASE
Approved
Mar 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CHLOR-TRIMETON (chlorpheniramine maleate; pseudoephedrine sulfate) by Bayer. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose and 1 more indications. First approved in 1981.
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHLOR-TRIMETON is an oral extended-release combination antihistamine (chlorpheniramine maleate) and nasal decongestant (pseudoephedrine sulfate) approved in 1981. It treats upper respiratory allergy symptoms including runny nose, itchy/watery eyes, sneezing, and throat itching due to hay fever and other allergies. The drug works by blocking histamine receptors to reduce allergic response and stimulating sympathetic receptors to constrict nasal blood vessels.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), suggesting defensive positioning and potential team consolidation or transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLOR-TRIMETON at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.